Hydrazine, its derivatives and their salts
Hydrazine, its derivatives and their salts is listed in Annex II as a prohibited substance for cosmetic products placed on the EU market.
Chemical identity and properties

Hydrazine
Hydrazine is a member of hydrazines and an azane. It has a role as an EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor. It is a conjugate base of a hydrazinium(1+). It is a conjugate acid of a hydrazinide. — ChEBI
- IUPAC name
- hydrazine
- Molecular formula
- H4N2
- Molecular weight
- 32.046 g/mol
- Exact mass
- 32.037448136 Da
- XLogP3
- -1.5
- Topological polar surface area
- 52.0 Ų
- Hydrogen-bond donors
- 2
- Hydrogen-bond acceptors
- 2
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
16 more reported names
External database identifiers
- ChEBI:CHEBI:15571
- ChEMBL:CHEMBL1237174
- EPA DTXSID:DTXSID3020702
- PubMed:21964329
- PubMed:12659765
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Record details
Chemical name
Hydrazine, its derivatives and their salts
Regulatory information
Identified ingredients
CMR
| Category | Carcinogenic | Mutagenic | Reprotoxic |
|---|---|---|---|
| Cat. 1B | ✓ | — | — |
Key data
Inventory links for Hydrazine, its derivatives and their salts
Related records for Hydrazine, its derivatives and their salts
Direct matches are limited for this record, so nearby entries from Annex II are shown as well.
Hydrazides and their salts e.g. Isoniazid (INN)
Hydrastine, hydrastinine and their salts
(1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene (Isodri…
Ethyl bis(4-hydroxy-2-oxo-1-benzopyran-3-yl)acetate and salts of the acid
(1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonapht…
1,2,3,4,5,6-Hexachlorocyclohexane (BHC-ISO)
4,4'-Dihydroxy-3,3'-(3-methylthiopropylidene) dicoumarin
What Annex II means for Hydrazine, its derivatives and their salts
Hydrazine, its derivatives and their salts is listed as a prohibited substance under Annex II of EU Cosmetics Regulation 1223/2009 and must not be intentionally added. Article 17 separately addresses unintended small quantities that are technically unavoidable under good manufacturing practice and compatible with the Article 3 safety requirement.
Formulators must screen their ingredients and raw materials to ensure none contain this substance. Suppliers should provide documentation confirming absence when requested.
This record is linked to 6 CosIng inventory ingredients for name and identifier cross-reference. The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.
Compliance checklist
- Verify this substance is absent from all raw materials and finished formulations.
- Request absence confirmation or CoA from raw material suppliers.
- Document the screening result in the Product Information File (PIF).
- This substance has CMR classification. Review the CMR table above and verify current Annex II/III status before use.
Frequently asked questions
Source note for Annex II record Hydrazine, its derivatives and their salts
This page summarizes one Annex II record for Hydrazine, its derivatives and their salts from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.
Use this record page to review Annex II conditions for Hydrazine, its derivatives and their salts, but confirm any final regulatory decision against the current official annex wording and source files.
Tools & next steps
Check your formula
Paste a full INCI list to detect Hydrazine, its derivatives and their salts and other flagged EU annex records in one pass.
INCI CheckerCompare entries
Compare Hydrazine, its derivatives and their salts side by side with another annex record to review differences in restrictions, concentrations and annex placement.
CompareBrowse the annex
See all records in Annex II and compare regulatory conditions across substances in this annex.
Open Annex II